compound introduction
芬布芬是联苯和4-氧代单羧酸的成员。它具有非甾体抗炎药的作用。
CAS number:36330-85-5 molecular formula:C16H14O3
芬布芬是联苯和4-氧代单羧酸的成员。它具有非甾体抗炎药的作用。
| Chinese alias | 4-(4-二苯基)-4-羰基丁酸 | γ-氧-(1,1'-联苯)-4-丁酸 | ||
| English alias | HMS2095L17 | STK202178 | Tox21_110638 | 3-(4-Phenyl)benzoyl propionic acid | NCGC00016834-01 | NSC 757812 | Prestwick1_000218 | Prestwick3_000218 | UNII-9815R1WR9B | Lederfen | NINDS_000025 | Opera_ID_464 | 4-biphenyl-4-yl-4-oxobutyric acid | 4-biphenyl-4 | ||
| CAS number | 36330-85-5 | molecular formula | C16H14O3 |
| molecular weight | 254.28 | Exact mass | ≥98% |
| PSA | 54.4 | logp | 3.2 |
| CAS | 36330-85-5 |
| UNII | 9815R1WR9B |
| HMDB ID | HMDB0252193 |
| KEGG ID | D01344 |
| ChEBI ID | 31599 |
| Wikidata | Q2304195 |
| ChEMBL ID | CHEMBL277522 |
| Wikipedia | Fenbufen |
| NSC Number | NSC Number: NSC757812 |
| DrugBank ID | DB08981 |
| DrugCentral | 1145 |
| PharmGKB ID | PA166049176 |
| PubChem CID | 3335 |
| Nikkaji Number | J3.182H |
| NCI 词表代码 | C80548 |
| Pharos Ligand ID | C2PB6W2R6N66 |
| DSSTox Substance ID | DTXSID9023043 |
| Metabolomics Workbench ID | 54424 |
| European Community (EC) Number | 252-979-0 |
| PubChem Reference Collection SID | 505594586 |
| United States Adopted Name (USAN) | FENBUFEN |
| International Nonproprietary Names (INN) | FENBUFEN |
| XLogP3 | 3.2 |
| 熔点 | 185-187 |
| 复杂性 | 310 |
| Exact Mass | 254.094294304 |
| Human Drugs | 药物 |
| 形式电荷 | 0 |
| 重原子计数 | 19 |
| Molecular Weight | 254.28 |
| Monoisotopic Mass | 254.094294304 |
| 可旋转键计数 | 5 |
| 氢键供体计数 | 1 |
| 氢键受体计数 | 3 |
| 共价键单元计数 | 1 |
| 同位素原子计数 | 0 |
| 拓扑极性表面积 | 54.4 Ų |
| Collision Cross Section | 184.5 Ų [M+K]+ [CCS类型:TW;方法:用聚丙氨酸和药物标准校准] |
| 定义键立体中心计数 | 0 |
| 定义原子立体中心计数 | 0 |
| 未定义键立体中心计数 | 0 |
| 未定义原子手性中心计数 | 0 |
No upstream information yet
No downstream information yet